{"id":297901,"date":"2026-10-09T11:34:36","date_gmt":"2026-10-09T06:04:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=297901"},"modified":"2026-10-09T11:34:36","modified_gmt":"2026-10-09T06:04:36","slug":"pfizer-vs-nifty-50-share-price-performance","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/","title":{"rendered":"Pfizer vs Nifty 50: Share Price Performance Compared"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Pfizer share price Rs 3,750.00 on NSE. Pfizer vs Nifty 50 over 1 year: -28.80% vs -11.71%. 52-week high Rs 5,578.50, low Rs 3,731.00.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Pfizer vs Nifty 50 favours the index: Pfizer has trailed the Nifty 50 across all five time frames measured, with a 1-year return of -28.80% against -11.71% for the benchmark. Over three years, Pfizer fell 5.32% while the Nifty 50 gained 13.94%, a gap of 19.26 percentage points against it. At Rs 3,750.00, Pfizer is 32.8% below its 52-week high of Rs 5,578.50 and 0.5% above its 52-week low of Rs 3,731.00. Returns use NSE closing prices to 8 October 2026, and past performance does not indicate future results.<\/p>\n<\/div>\n<p>Pfizer vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Pfizer trades on the NSE under the symbol PFIZER, and its 1-month return of -10.09% compares with -5.12% for the Nifty 50 over the same period.<\/p>\n<p>The Pfizer vs Nifty 50 comparison matters because Pfizer is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Pfizer share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 8 October 2026.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/pc-jeweller-vs-nifty-50-share-price-performance\">PC Jeweller vs Nifty 50: Returns Compared<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pfizer-vs-nifty50\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Pfizer_vs_Nifty_50_Performance_at_a_Glance\" title=\"Pfizer vs Nifty 50: Performance at a Glance\">Pfizer vs Nifty 50: Performance at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Latest_Close_and_52-Week_Range_Pfizer_and_the_Nifty_50\" title=\"Latest Close and 52-Week Range: Pfizer and the Nifty 50\">Latest Close and 52-Week Range: Pfizer and the Nifty 50<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Why_the_Pfizer_vs_Nifty_50_Gap_Exists\" title=\"Why the Pfizer vs Nifty 50 Gap Exists\">Why the Pfizer vs Nifty 50 Gap Exists<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Pfizer_vs_Nifty_50_Has_Pfizer_Beaten_the_Benchmark\" title=\"Pfizer vs Nifty 50: Has Pfizer Beaten the Benchmark?\">Pfizer vs Nifty 50: Has Pfizer Beaten the Benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Risks_of_the_Pfizer_vs_Nifty_50_Comparison\" title=\"Risks of the Pfizer vs Nifty 50 Comparison\">Risks of the Pfizer vs Nifty 50 Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Has_Pfizer_outperformed_the_Nifty_50_in_the_last_year\" title=\"Has Pfizer outperformed the Nifty 50 in the last year?\">Has Pfizer outperformed the Nifty 50 in the last year?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#How_does_Pfizer_vs_Nifty_50_look_over_3_years\" title=\"How does Pfizer vs Nifty 50 look over 3 years?\">How does Pfizer vs Nifty 50 look over 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#What_is_the_Pfizer_share_price_today_compared_to_Nifty_50\" title=\"What is the Pfizer share price today compared to Nifty 50?\">What is the Pfizer share price today compared to Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#What_is_the_52-week_high_and_low_of_Pfizer\" title=\"What is the 52-week high and low of Pfizer?\">What is the 52-week high and low of Pfizer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Why_does_Pfizer_show_bigger_price_swings_than_the_Nifty_50\" title=\"Why does Pfizer show bigger price swings than the Nifty 50?\">Why does Pfizer show bigger price swings than the Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-vs-nifty-50-share-price-performance\/#Is_Pfizer_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\" title=\"Is Pfizer a good long-term investment compared to a Nifty 50 index fund?\">Is Pfizer a good long-term investment compared to a Nifty 50 index fund?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_vs_Nifty_50_Performance_at_a_Glance\"><\/span><strong>Pfizer vs Nifty 50: Performance at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets out the Pfizer vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.<\/p>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th>Time Frame<\/th>\n<th>Pfizer Return<\/th>\n<th>Nifty 50 Return<\/th>\n<th>Difference<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 Month<\/td>\n<td>-10.09%<\/td>\n<td>-5.12%<\/td>\n<td>-4.97 pp<\/td>\n<\/tr>\n<tr>\n<td>3 Months<\/td>\n<td>-18.30%<\/td>\n<td>-7.22%<\/td>\n<td>-11.08 pp<\/td>\n<\/tr>\n<tr>\n<td>6 Months<\/td>\n<td>-21.04%<\/td>\n<td>-6.49%<\/td>\n<td>-14.55 pp<\/td>\n<\/tr>\n<tr>\n<td>1 Year<\/td>\n<td>-28.80%<\/td>\n<td>-11.71%<\/td>\n<td>-17.09 pp<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>-5.32%<\/td>\n<td>+13.94%<\/td>\n<td>-19.26 pp<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On the Pfizer vs Nifty 50 scorecard, Pfizer has trailed the index over the latest 1-year window, returning -28.80% against -11.71% for the Nifty 50, a difference of 17.09 percentage points. The widest gap on the table is over three years, where Pfizer fell 5.32% while the Nifty 50 gained 13.94%, a difference of 19.26 percentage points against the stock. Both Pfizer and the index lost ground over the past year, so the comparison here is about which of the two lost less.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Pfizer and Nifty 50 data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Latest_Close_and_52-Week_Range_Pfizer_and_the_Nifty_50\"><\/span><strong>Latest Close and 52-Week Range: Pfizer and the Nifty 50<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th>Instrument<\/th>\n<th>Latest Close<\/th>\n<th>52-Week High<\/th>\n<th>52-Week Low<\/th>\n<th>Vs 52-Week High<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer<\/a><\/td>\n<td>Rs 3,750.00<\/td>\n<td>Rs 5,578.50<\/td>\n<td>Rs 3,731.00<\/td>\n<td>-32.8%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a><\/td>\n<td>22,231.80<\/td>\n<td>26,373.20<\/td>\n<td>22,179.90<\/td>\n<td>-15.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pfizer closed at Rs 3,750.00 on 8 October 2026, which is 32.8% below its 52-week high of Rs 5,578.50 and 0.5% above its 52-week low of Rs 3,731.00. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_the_Pfizer_vs_Nifty_50_Gap_Exists\"><\/span><strong>Why the Pfizer vs Nifty 50 Gap Exists<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Pfizer has traded between Rs 3,731.00 and Rs 5,578.50, a spread of 49.5% from low to high, against 18.9% for the Nifty 50.<\/p>\n<p>Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move Pfizer&#8217;s price sharply in either direction, while the Nifty 50&#8217;s return reflects the blended earnings of its constituents and is far less exposed to any single company&#8217;s news.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Pfizer and Nifty 50 live on the go.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_vs_Nifty_50_Has_Pfizer_Beaten_the_Benchmark\"><\/span><strong>Pfizer vs Nifty 50: Has Pfizer Beaten the Benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No, not over the past year. Pfizer returned -28.80% against -11.71% for the Nifty 50, a shortfall of 17.09 percentage points. Across all five time frames measured, Pfizer is behind the index.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_of_the_Pfizer_vs_Nifty_50_Comparison\"><\/span><strong>Risks of the Pfizer vs Nifty 50 Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reading too much into a Pfizer vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/pine-labs-vs-nifty-50-share-price-performance\">Pine Labs vs Nifty 50: Returns Compared<\/a><\/p>\n<p>Pfizer carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 3,731.00 to Rs 5,578.50 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer vs Nifty 50 currently reads in the index&#8217;s favour on every time frame measured, with the widest shortfall over three years. That does not rule out a change in direction, but investors should factor Pfizer&#8217;s volatility, liquidity and sector concentration into any decision and consult a SEBI-registered advisor first.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Has_Pfizer_outperformed_the_Nifty_50_in_the_last_year\"><\/span><strong>Has Pfizer outperformed the Nifty 50 in the last year?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. Pfizer returned -28.80% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Pfizer_vs_Nifty_50_look_over_3_years\"><\/span><strong>How does Pfizer vs Nifty 50 look over 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Over three years Pfizer has returned -5.32% compared with the Nifty 50&#8217;s +13.94%, so in the Pfizer vs Nifty 50 comparison the stock has been behind over this horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Pfizer_share_price_today_compared_to_Nifty_50\"><\/span><strong>What is the Pfizer share price today compared to Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer share price closed at Rs 3,750.00 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_and_low_of_Pfizer\"><\/span><strong>What is the 52-week high and low of Pfizer?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer&#8217;s 52-week high is Rs 5,578.50 and its 52-week low is Rs 3,731.00, based on NSE data. The latest close of Rs 3,750.00 is 32.8% below the high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_Pfizer_show_bigger_price_swings_than_the_Nifty_50\"><\/span><strong>Why does Pfizer show bigger price swings than the Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Pfizer has traded in a 49.5% low-to-high range against 18.9% for the index, a key reason the Pfizer vs Nifty 50 return gap varies across time frames.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Pfizer_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\"><\/span><strong>Is Pfizer a good long-term investment compared to a Nifty 50 index fund?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer&#8217;s suitability depends on an investor&#8217;s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Pfizer vs Nifty 50 return history alongside the company&#8217;s fundamentals and consult a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Has Pfizer outperformed the Nifty 50 in the last year?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Pfizer returned -28.80% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.\"}},{\"@type\":\"Question\",\"name\":\"How does Pfizer vs Nifty 50 look over 3 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Over three years Pfizer has returned -5.32% compared with the Nifty 50's +13.94%, so in the Pfizer vs Nifty 50 comparison the stock has been behind over this horizon.\"}},{\"@type\":\"Question\",\"name\":\"What is the Pfizer share price today compared to Nifty 50?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer share price closed at Rs 3,750.00 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.\"}},{\"@type\":\"Question\",\"name\":\"What is the 52-week high and low of Pfizer?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer's 52-week high is Rs 5,578.50 and its 52-week low is Rs 3,731.00, based on NSE data. The latest close of Rs 3,750.00 is 32.8% below the high.\"}},{\"@type\":\"Question\",\"name\":\"Why does Pfizer show bigger price swings than the Nifty 50?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Pfizer has traded in a 49.5% low-to-high range against 18.9% for the index, a key reason the Pfizer vs Nifty 50 return gap varies across time frames.\"}},{\"@type\":\"Question\",\"name\":\"Is Pfizer a good long-term investment compared to a Nifty 50 index fund?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Pfizer vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>How does Pfizer compare to the Nifty 50? See share price performance, returns and key data points.<\/p>\n","protected":false},"author":35,"featured_media":297899,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[708,1019],"class_list":["post-297901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-nifty-50","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["297899"],"rank_math_title":["Pfizer vs Nifty 50: 1Y Return -28.80% vs -11.71%"],"rank_math_description":["Pfizer vs Nifty 50: compare the Pfizer share price with the Nifty 50 over 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data to 8 October 2026."],"rank_math_focus_keyword":["Pfizer vs Nifty 50"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/pfizer-vs-nifty-50-share-price-performance-compared.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/297901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=297901"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/297901\/revisions"}],"predecessor-version":[{"id":297903,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/297901\/revisions\/297903"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/297899"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=297901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=297901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=297901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}